| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | endocardial cell differentiation | 2.11e-05 | 6 | 25 | 2 | GO:0060956 | |
| GeneOntologyBiologicalProcess | cardiac endothelial cell differentiation | 3.93e-05 | 8 | 25 | 2 | GO:0003348 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | 4.34e-05 | 333 | 25 | 5 | GO:0051056 | |
| GeneOntologyBiologicalProcess | endocardium development | 1.09e-04 | 13 | 25 | 2 | GO:0003157 | |
| GeneOntologyBiologicalProcess | positive regulation of small GTPase mediated signal transduction | 1.84e-04 | 92 | 25 | 3 | GO:0051057 | |
| Domain | WD40_repeat_CS | 5.31e-05 | 164 | 24 | 4 | IPR019775 | |
| Domain | WD40 | 3.09e-04 | 259 | 24 | 4 | PF00400 | |
| Domain | WD40 | 3.51e-04 | 268 | 24 | 4 | SM00320 | |
| Domain | WD40_repeat | 3.72e-04 | 272 | 24 | 4 | IPR001680 | |
| Domain | WD_REPEATS_1 | 4.04e-04 | 278 | 24 | 4 | PS00678 | |
| Domain | WD_REPEATS_2 | 4.09e-04 | 279 | 24 | 4 | PS50082 | |
| Domain | WD_REPEATS_REGION | 4.09e-04 | 279 | 24 | 4 | PS50294 | |
| Domain | WD40_repeat_dom | 5.18e-04 | 297 | 24 | 4 | IPR017986 | |
| Domain | - | 7.95e-04 | 333 | 24 | 4 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 8.13e-04 | 335 | 24 | 4 | IPR015943 | |
| Domain | Ig_I-set | 1.79e-03 | 190 | 24 | 3 | IPR013098 | |
| Domain | I-set | 1.79e-03 | 190 | 24 | 3 | PF07679 | |
| Domain | IGc2 | 3.27e-03 | 235 | 24 | 3 | SM00408 | |
| Domain | Ig_sub2 | 3.27e-03 | 235 | 24 | 3 | IPR003598 | |
| Domain | IG | 1.62e-02 | 421 | 24 | 3 | SM00409 | |
| Domain | Ig_sub | 1.62e-02 | 421 | 24 | 3 | IPR003599 | |
| Domain | fn3 | 1.82e-02 | 162 | 24 | 2 | PF00041 | |
| Pathway | REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING | 4.80e-05 | 8 | 19 | 2 | M27351 | |
| Pubmed | Mesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis. | 5.37e-06 | 5 | 26 | 2 | 28287406 | |
| Pubmed | 6.41e-05 | 16 | 26 | 2 | 8467795 | ||
| Pubmed | 7.26e-05 | 17 | 26 | 2 | 21435555 | ||
| Pubmed | 2.47e-04 | 31 | 26 | 2 | 22282597 | ||
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 2.75e-04 | 170 | 26 | 3 | 23314748 | |
| Pubmed | 4.41e-04 | 486 | 26 | 4 | 20936779 | ||
| Pubmed | 4.66e-04 | 493 | 26 | 4 | 15368895 | ||
| Pubmed | 5.22e-04 | 45 | 26 | 2 | 21041608 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 2.18e-03 | 122 | 26 | 2 | chr19p12 | |
| GeneFamily | WD repeat domain containing | 1.12e-04 | 262 | 18 | 4 | 362 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.13e-04 | 161 | 18 | 3 | 593 | |
| GeneFamily | Fibronectin type III domain containing | 1.09e-02 | 160 | 18 | 2 | 555 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.07e-06 | 182 | 25 | 4 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.27e-06 | 185 | 25 | 4 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.49e-06 | 188 | 25 | 4 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.79e-06 | 192 | 25 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.87e-06 | 193 | 25 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.03e-06 | 195 | 25 | 4 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.11e-06 | 196 | 25 | 4 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.28e-06 | 198 | 25 | 4 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.28e-06 | 198 | 25 | 4 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.28e-06 | 198 | 25 | 4 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.28e-06 | 198 | 25 | 4 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.28e-06 | 198 | 25 | 4 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 4.46e-06 | 200 | 25 | 4 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | PBMC-Control-cDC_2|Control / Compartment, Disease Groups and Clusters | 8.39e-05 | 153 | 25 | 3 | 4ee37266b0054f276c7a73ab9220f681b9d74c71 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.06e-05 | 157 | 25 | 3 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.41e-05 | 159 | 25 | 3 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 167 | 25 | 3 | 8b223333c0c7a85b5a1af6f2f5b12ee0d94357f6 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.11e-04 | 168 | 25 | 3 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 170 | 25 | 3 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 170 | 25 | 3 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 170 | 25 | 3 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 170 | 25 | 3 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 170 | 25 | 3 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination__)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 171 | 25 | 3 | d1e87478d8c0329e662849823f5c7604f20e1b1a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-04 | 172 | 25 | 3 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.19e-04 | 172 | 25 | 3 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-04 | 172 | 25 | 3 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-04 | 174 | 25 | 3 | fdadac1eaab2c4a67e4832f0901df22e893add6a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-04 | 174 | 25 | 3 | 8d8cf8ad17dcc364f867e36b10834a21c0e36ad2 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-04 | 177 | 25 | 3 | 84116796ca4c7007508c0f1a68a1135c7b922278 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-04 | 178 | 25 | 3 | 3c973aac16988e88f5677d3d695dd772ccfd6570 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.31e-04 | 178 | 25 | 3 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 178 | 25 | 3 | de6cd81e6d58e7687386df163471bf1901b9c0aa | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-04 | 179 | 25 | 3 | 97ba67a856680f24846244c0b92c886cc0e79537 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-04 | 179 | 25 | 3 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-04 | 180 | 25 | 3 | efc4c5a4dea456527526bbfd88cf70d803893671 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-4|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.36e-04 | 180 | 25 | 3 | 886ebaf9cf8992e8dd13fca799a1d1a2a9ce73d8 | |
| ToppCell | critical-Lymphoid-NK|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.36e-04 | 180 | 25 | 3 | 5abf778395392244daaec876f306ed7e4f388686 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-04 | 181 | 25 | 3 | 062f00736eed96e4f4327615d093558dd7d82b20 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-04 | 181 | 25 | 3 | 7846c7b33d1b89364c5a704edaa86520db731c89 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-04 | 182 | 25 | 3 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-04 | 182 | 25 | 3 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-04 | 183 | 25 | 3 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-DC1|Lung / Manually curated celltypes from each tissue | 1.43e-04 | 183 | 25 | 3 | e4cbd39575b5a4612d9934532e3bad63286f8aa5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-04 | 184 | 25 | 3 | 32473dbdb2de66391157c5814ef34e790806e4f2 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-04 | 184 | 25 | 3 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-04 | 184 | 25 | 3 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | Control-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 1.45e-04 | 184 | 25 | 3 | c6affa0b12510363258f65e46bf2d47bf4a8e75f | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.45e-04 | 184 | 25 | 3 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Dendritic-DC1|GI_small-bowel / Manually curated celltypes from each tissue | 1.45e-04 | 184 | 25 | 3 | 8e393eea7240584a3cef718bee094e2705ec1891 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.47e-04 | 185 | 25 | 3 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 1.47e-04 | 185 | 25 | 3 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.47e-04 | 185 | 25 | 3 | bdfa8c284bbc5e85c806327fbb7778cf16242a38 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-04 | 186 | 25 | 3 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-DC1|Liver / Manually curated celltypes from each tissue | 1.50e-04 | 186 | 25 | 3 | e823529ffd06352c6bdec102f221fdf27f7c7369 | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease state, Lineage and Cell class | 1.50e-04 | 186 | 25 | 3 | b05c394aa3573ba855abc3066739ca193883b0c3 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-04 | 187 | 25 | 3 | ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.52e-04 | 187 | 25 | 3 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.54e-04 | 188 | 25 | 3 | 6ee3f8f94ea7bdf652c9575fc65bff08070093a4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 189 | 25 | 3 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 189 | 25 | 3 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 1.57e-04 | 189 | 25 | 3 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.59e-04 | 190 | 25 | 3 | d24af6af3271e34afab744352afd28be8a7cc5c3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 190 | 25 | 3 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.59e-04 | 190 | 25 | 3 | d594da827e3c16644952b9589cc12b947ce36279 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 190 | 25 | 3 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-04 | 190 | 25 | 3 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 191 | 25 | 3 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.62e-04 | 191 | 25 | 3 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 191 | 25 | 3 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-04 | 192 | 25 | 3 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-04 | 192 | 25 | 3 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-04 | 192 | 25 | 3 | 67d6230e32d446dcb12047fae2c3f1faa80dd720 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.64e-04 | 192 | 25 | 3 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-04 | 192 | 25 | 3 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 192 | 25 | 3 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.67e-04 | 193 | 25 | 3 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.67e-04 | 193 | 25 | 3 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.67e-04 | 193 | 25 | 3 | 2f203f6f0c2135acb046c9351a633c3b5b254a46 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.67e-04 | 193 | 25 | 3 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-04 | 194 | 25 | 3 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-04 | 194 | 25 | 3 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.72e-04 | 195 | 25 | 3 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.72e-04 | 195 | 25 | 3 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.74e-04 | 196 | 25 | 3 | 7af6c5147ac859353504d19727dbe24f63a29dd4 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.74e-04 | 196 | 25 | 3 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.74e-04 | 196 | 25 | 3 | b07db4a53ab9be9aad6fae5e45f9547db829d096 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.74e-04 | 196 | 25 | 3 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.77e-04 | 197 | 25 | 3 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 197 | 25 | 3 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.77e-04 | 197 | 25 | 3 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.80e-04 | 198 | 25 | 3 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-04 | 198 | 25 | 3 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.82e-04 | 199 | 25 | 3 | e9c83555d2197b740797a9f33b64f8f7a7ba1ee2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.82e-04 | 199 | 25 | 3 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.82e-04 | 199 | 25 | 3 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-ADAMTSL1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.85e-04 | 200 | 25 | 3 | e1fca7ee2dc18c7fded53c3561f519c1fcd9767a | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CBLN1-L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.85e-04 | 200 | 25 | 3 | 2086024ce808b8796ed508a229b098eb02f8828a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.85e-04 | 200 | 25 | 3 | ef222dc4a205d670172dae74990bdb952ac92e5b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.85e-04 | 200 | 25 | 3 | 332905a686356cd1e024d40679be98e9d8b1b5e8 | |
| Drug | Vanadates | 5.64e-06 | 1302 | 25 | 9 | ctd:D014638 | |
| Disease | a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement | 1.01e-04 | 17 | 26 | 2 | EFO_0008011 | |
| Disease | response to vaccine, cytokine measurement | 2.06e-04 | 131 | 26 | 3 | EFO_0004645, EFO_0004873 | |
| Disease | internet addiction disorder | 3.88e-04 | 33 | 26 | 2 | EFO_0803368 | |
| Disease | asthma | 4.45e-04 | 751 | 26 | 5 | MONDO_0004979 | |
| Disease | Alzheimer disease | 8.09e-04 | 485 | 26 | 4 | MONDO_0004975 | |
| Disease | Hepatic fibrosis | 8.56e-04 | 49 | 26 | 2 | HP_0001395 | |
| Disease | hair morphology measurement | 1.04e-03 | 54 | 26 | 2 | EFO_0007821 | |
| Disease | ovarian cancer (is_implicated_in) | 1.12e-03 | 56 | 26 | 2 | DOID:2394 (is_implicated_in) | |
| Disease | age at initiation of smoking | 1.55e-03 | 66 | 26 | 2 | EFO_0021784 | |
| Disease | Lung Neoplasms | 1.60e-03 | 265 | 26 | 3 | C0024121 | |
| Disease | Malignant neoplasm of lung | 1.62e-03 | 266 | 26 | 3 | C0242379 | |
| Disease | ovarian cancer (is_marker_for) | 1.64e-03 | 68 | 26 | 2 | DOID:2394 (is_marker_for) | |
| Disease | Contact hypersensitivity | 1.79e-03 | 71 | 26 | 2 | C0162351 | |
| Disease | Contact Dermatitis | 1.79e-03 | 71 | 26 | 2 | C0011616 | |
| Disease | psychotic symptoms | 1.94e-03 | 74 | 26 | 2 | EFO_0005940 | |
| Disease | white matter hyperintensity measurement | 2.32e-03 | 302 | 26 | 3 | EFO_0005665 | |
| Disease | response to selective serotonin reuptake inhibitor | 2.37e-03 | 82 | 26 | 2 | EFO_0005658 | |
| Disease | carotid plaque build | 2.49e-03 | 84 | 26 | 2 | EFO_0006501 | |
| Disease | Eczema | 2.50e-03 | 310 | 26 | 3 | HP_0000964 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TKAHLFSTGTVHWVP | 161 | Q15822 | |
| QVSTHKQSESSHGWT | 796 | P20930 | |
| ASSWTIHQHSFKVGT | 931 | A2RUS2 | |
| AHHSTTVTQTPSHSW | 341 | Q02297 | |
| TVTQTPSHSWSNGHT | 346 | Q02297 | |
| PSHSWSNGHTESILS | 351 | Q02297 | |
| WVTSSEHASHSTIPA | 3956 | Q8WXI7 | |
| HTSPHGISSICWSSN | 31 | Q8NHV4 | |
| EHHTTGLTWSKTGPV | 201 | P40123 | |
| KHQNTPSIGLHWRSS | 96 | A0A1B0GTH6 | |
| PHLGVSGSSTKWHSE | 16 | Q6ZVL6 | |
| SSPHHILTWQTGEAT | 1006 | Q9P2Q2 | |
| KTSVPHHVVWSLFNT | 51 | C9JQL5 | |
| SSIPIQGHSHWEETS | 166 | Q8N5D6 | |
| EHWISQAIHGSTTST | 161 | Q9Y2E4 | |
| HSQSWSTKTPTVLGH | 391 | Q5VV63 | |
| AWTSAASSVKPQHQH | 646 | Q13495 | |
| HGIGTASWNHSTTVP | 241 | Q8IX15 | |
| VSPNSSHSHAVVLSW | 676 | Q7Z5N4 | |
| THHWISFSGRPSSVS | 86 | Q9C004 | |
| HHNSTTTWTGSRTAP | 261 | Q13485 | |
| NGIKTFTWSSSPHKH | 96 | Q6ZT77 | |
| SWTHSKARTPEGTHS | 241 | A0A1B0GUW6 | |
| SGHTAKITSVAWSPH | 636 | Q8TEQ6 | |
| SNVAHHSKVTLWSGS | 2186 | Q6ZS81 | |
| HNPTVLSSSSIEVHW | 681 | Q9Y6N7 | |
| SNSTTWHRLHPTDGS | 666 | Q86YV5 | |
| NWPSTLTKHNRIHTG | 436 | P17038 | |
| LTWSPGSVTNTSLAH | 1701 | Q8NDV7 | |
| KSSTWTGSQNTVHHI | 196 | Q8NC26 |